miltefosine has been researched along with B-Cell Chronic Lymphocytic Leukemia in 2 studies
miltefosine: hexadecyl phosphocholine derivative of cisplatin; did not substantially activate HIV long terminal repeat; less toxic than cisplatin
miltefosine : A phospholipid that is the hexadecyl monoester of phosphocholine.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Teh, JSK | 1 |
Tam, PCK | 1 |
Badenoch, PR | 1 |
Adamson, PJ | 1 |
Brennan, C | 1 |
Marshman, G | 1 |
Gordon, DL | 1 |
Gee, SN | 1 |
Rothschild, B | 1 |
Click, J | 1 |
Sheth, V | 1 |
Saavedra, A | 1 |
Hsu, MY | 1 |
2 other studies available for miltefosine and B-Cell Chronic Lymphocytic Leukemia
Article | Year |
---|---|
Successful treatment of cutaneous Acanthamoeba castellanii infection with miltefosine in a patient with chronic lymphocytic leukaemia on ibrutinib.
Topics: Acanthamoeba castellanii; Adenine; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Phosphorylcholine | 2022 |
Tender ulceronecrotic nodules in a patient with leukemia. Cutaneous acanthamebiasis.
Topics: Acanthamoeba; Amebiasis; Antiprotozoal Agents; Drug Therapy, Combination; Female; Fluconazole; Flucy | 2011 |